Biomarkers in Exhaled Breath Condensates of Septic Patients to Predict Development of Multi-organ Dysfunction Syndrome
NCT01503684 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2012-01-04
Summary
In this proposal, the investigators wish to investigate, identify and validate potential biomarkers in collected exhaled breath condensates (EBC) from patients with sepsis.
Conditions
Interventions
- OTHER
-
Determined by intended physician
We perform a prospective observational study. All the treatment for the patients are determined by intended physicians.
Sponsors & Collaborators
-
National Science and Technology Council, Taiwan
collaborator OTHER_GOV -
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Jih-Shuin Jerng, MD, PhD · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 ·Status: COMPLETED
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation
NCT01362829 ·Status: COMPLETED
-
Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
NCT02544490 ·Status: COMPLETED
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
NCT02887274 ·Status: UNKNOWN
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Detection of Sepsis Occurrence by Using Blood Fluorescence
NCT06689189 ·Status: RECRUITING
-
Molecular Subtype-Specific Mechanisms and Therapeutic Strategies in Sepsis
NCT06287684 ·Status: RECRUITING
-
Risk Factors for Adverse Outcomes in Sepsis
NCT06541600 ·Status: COMPLETED
-
Endothelium in Severe Sepsis
NCT00793442 ·Status: COMPLETED
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis
NCT01535534 ·Status: UNKNOWN
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Mitochondrial Function in Septic Patients
NCT03748537 ·Status: COMPLETED ·Phase: NA
-
The Prognostic Value of Lactate is Different Among Septic Patients
NCT04155060 ·Status: COMPLETED
-
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
NCT06817408 ·Status: RECRUITING
-
Dendritic Cells-Derived Exosomes in Human Sepsis
NCT02957279 ·Status: UNKNOWN
-
Host Dysregulation-Driven Sepsis Prediction Model
NCT06523075 ·Status: COMPLETED
-
Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1
NCT04718623 ·Status: UNKNOWN
-
Zinc and Inflammation in Sepsis
NCT01328509 ·Status: COMPLETED